Centerpoint Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Hold |
4,000
| – | – | 0.15% | 55 |
|
|
2025
Q1 | $404K | Hold |
4,000
| – | – | 0.15% | 56 |
|
|
2024
Q4 | $357K | Hold |
4,000
| – | – | 0.13% | 64 |
|
|
2024
Q3 | $335K | Hold |
4,000
| – | – | 0.12% | 66 |
|
|
2024
Q2 | $308K | Hold |
4,000
| – | – | 0.11% | 68 |
|
|
2024
Q1 | $274K | Hold |
4,000
| – | – | 0.1% | 75 |
|
|
2023
Q4 | $231K | Sell |
4,000
-18
| -0.4% | -$1.04K | 0.09% | 78 |
|
|
2023
Q3 | $212K | Hold |
4,018
| – | – | 0.09% | 86 |
|
|
2023
Q2 | $217K | Hold |
4,018
| – | – | 0.09% | 84 |
|
|
2023
Q1 | $201K | Buy |
4,018
+18
| +0.5% | +$900 | 0.09% | 97 |
|
|
2022
Q4 | $185K | Sell |
4,000
-94
| -2% | -$4.35K | 0.09% | 90 |
|
|
2022
Q3 | $159K | Hold |
4,094
| – | – | 0.08% | 89 |
|
|
2022
Q2 | $153K | Hold |
4,094
| – | – | 0.08% | 93 |
|
|
2022
Q1 | $181K | Hold |
4,094
| – | – | 0.08% | 90 |
|
|
2021
Q4 | $174K | Hold |
4,094
| – | – | 0.08% | 93 |
|
|
2021
Q3 | $178K | Hold |
4,094
| – | – | 0.08% | 91 |
|
|
2021
Q2 | $175K | Buy |
4,094
+4,000
| +4,255% | +$171K | 0.08% | 94 |
|
|
2021
Q1 | $4K | Hold |
94
| – | – | ﹤0.01% | 211 |
|
|
2020
Q4 | $3K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2020
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 192 |
|
|
2020
Q2 | $3K | Hold |
94
| – | – | ﹤0.01% | 233 |
|
|
2020
Q1 | $3K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2019
Q4 | $4K | Hold |
94
| – | – | ﹤0.01% | 219 |
|
|
2019
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2019
Q2 | $4K | Hold |
94
| – | – | ﹤0.01% | 198 |
|
|
2019
Q1 | $4K | Hold |
94
| – | – | ﹤0.01% | 191 |
|
|
2018
Q4 | $3K | Hold |
94
| – | – | ﹤0.01% | 196 |
|
|
2018
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 181 |
|
|
2018
Q2 | $3K | Buy |
94
+61
| +185% | +$1.95K | ﹤0.01% | 237 |
|
|
2018
Q1 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 225 |
|